Animal Vaccines Market
Animal Vaccines Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines
- By Animal Type Livestock, Companion
- By Route of Administration Subcutaneous, Intramuscular, Intranasal
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2023 |
Forecast Years: | 2024 - 2032 |
Historical Years: | 2018 - 2022 |
Revenue 2023: | USD 9.9 Billion |
Revenue 2032: | USD 15.9 Billion |
Revenue CAGR (2024 - 2032): | 6.0% |
Fastest Growing Region (2024 - 2032) | Asia Pacific |
Largest Region (2023): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Animal Vaccines Market - Segment Analysis
- Overview
- Global Animal Vaccines Market, 2016 - 2028 (USD Million)
-
Global Animal Vaccines Market - by Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
-
Global Animal Vaccines Market - by Animal Type
- By Livestock
- By Companion
-
Global Animal Vaccines Market - by Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
-
Global Animal Vaccines Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Animal Vaccines Market - Segment Analysis
- Overview
- North America Animal Vaccines Market, 2016 - 2028 (USD Million)
-
North America Animal Vaccines Market, by Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
-
North America Animal Vaccines Market, by Animal Type
- By Livestock
- By Companion
-
North America Animal Vaccines Market, by Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
-
North America Animal Vaccines Market, by Country
- U.S.
- U.S. Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- U.S. Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- U.S. Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- U.S. Animal Vaccines Market, By Product
- Canada
- Canada Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Canada Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Canada Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Canada Animal Vaccines Market, By Product
- Mexico
- Mexico Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Mexico Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Mexico Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Mexico Animal Vaccines Market, By Product
- U.S.
-
Europe Animal Vaccines Market - Segment Analysis
- Overview
- Europe Animal Vaccines Market, 2016 - 2028 (USD Million)
-
Europe Animal Vaccines Market, by Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
-
Europe Animal Vaccines Market, by Animal Type
- By Livestock
- By Companion
-
Europe Animal Vaccines Market, by Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
-
Europe Animal Vaccines Market, by Country
- Germany
- Germany Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Germany Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Germany Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Germany Animal Vaccines Market, By Product
- UK
- UK Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- UK Market, By Animal Type
- By Livestock
- By Companion
- UK Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- UK Market, By Product
- France
- France Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- France Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- France Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- France Animal Vaccines Market, By Product
- Spain
- Spain Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Spain Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Spain Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Spain Animal Vaccines Market, By Product
- Italy
- Italy Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Italy Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Italy Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Italy Animal Vaccines Market, By Product
- BENELUX
- BENELUX Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- BENELUX Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- BENELUX Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- BENELUX Animal Vaccines Market, By Product
- Rest of Europe
- Rest Of Europe Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Rest Of Europe Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Rest Of Europe Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Rest Of Europe Animal Vaccines Market, By Product
- Germany
-
Asia Pacific Animal Vaccines Market - Segment Analysis
- Overview
- Asia Pacific Animal Vaccines Market, 2016 - 2028 (USD Million)
-
Asia Pacific Animal Vaccines Market, by Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
-
Asia Pacific Animal Vaccines Market, by Animal Type
- By Livestock
- By Companion
-
Asia Pacific Animal Vaccines Market, by Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
-
Asia Pacific Animal Vaccines Market, by Country
- China
- China Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- China Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- China Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- China Animal Vaccines Market, By Product
- Japan
- Japan Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Japan Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Japan Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Japan Animal Vaccines Market, By Product
- India
- India Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- India Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- India Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- India Animal Vaccines Market, By Product
- South Korea
- South Korea Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- South Korea Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- South Korea Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- South Korea Animal Vaccines Market, By Product
- South East Asia
- South East Asia Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- South East Asia Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- South East Asia Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- South East Asia Animal Vaccines Market, By Product
- Rest of Asia Pacific
- Rest of Asia Pacific Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Rest of Asia Pacific Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Rest of Asia Pacific Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Rest of Asia Pacific Animal Vaccines Market, By Product
- China
-
Latin America Animal Vaccines Market - Segment Analysis
- Overview
- Latin America Animal Vaccines Market, 2016 - 2028 (USD Million)
-
Latin America Animal Vaccines Market, by Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
-
Latin America Animal Vaccines Market, by Animal Type
- By Livestock
- By Companion
-
Latin America Animal Vaccines Market, by Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
-
Latin America Animal Vaccines Market, by Country
- Brazil
- Brazil Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Brazil Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Brazil Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Brazil Animal Vaccines Market, By Product
- Argentina
- Argentina Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Argentina Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Argentina Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Argentina Animal Vaccines Market, By Product
- Rest of Latin America
- Rest of Latin America Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Rest of Latin America Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Rest of Latin America Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Rest of Latin America Animal Vaccines Market, By Product
- Brazil
-
Middle East & Africa Animal Vaccines Market - Segment Analysis
- Overview
- Middle East & Africa Animal Vaccines Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Animal Vaccines Market, by Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
-
Middle East & Africa Animal Vaccines Market, by Animal Type
- By Livestock
- By Companion
-
Middle East & Africa Animal Vaccines Market, by Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
-
Middle East & Africa Animal Vaccines Market, by Country
- GCC Countries
- GCC Countries Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- GCC Countries Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- GCC Countries Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- GCC Countries Animal Vaccines Market, By Product
- South Africa
- South Africa Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- South Africa Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- South Africa Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- South Africa Animal Vaccines Market, By Product
- Rest of Middle East & Africa
- Rest of Middle East & Africa Animal Vaccines Market, By Product
- By Attenuated Live Vaccines
- By Inactivated Vaccines
- By Subunit Vaccines
- By DNA Vaccines
- By Recombinant Vaccines
- Rest of Middle East & Africa Animal Vaccines Market, By Animal Type
- By Livestock
- By Companion
- Rest of Middle East & Africa Animal Vaccines Market, By Route of Administration
- By Subcutaneous
- By Intramuscular
- By Intranasal
- Rest of Middle East & Africa Animal Vaccines Market, By Product
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Zoetis
- Ceva Santé Animale
- Merck & Co. Inc.
- Vetoquinol S.A.
- Boehringer Ingelheim Gmbh
- Elanco
- Virbac
- Heska
- Dechra Pharmaceuticals Plc
- Idexx Laboratories Inc.
- Norbrook Inc.
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Animal Vaccines in terms of revenue?
-
The global Animal Vaccines valued at USD 9.9 Billion in 2023 and is expected to reach USD 15.9 Billion in 2032 growing at a CAGR of 6.0%.
Which are the prominent players in the market?
-
The prominent players in the market are Zoetis, Ceva Santé Animale, Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim Gmbh, Elanco, Virbac, Heska, Dechra Pharmaceuticals Plc, Idexx Laboratories, Inc., Norbrook Inc..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.0% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Animal Vaccines include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Animal Vaccines in 2023.